Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses
2010

Intranasal Immunization with DNA Vaccine for SARS

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): Shim Byoung-Shik, Park Sung-Moo, Quan Ji-Shan, Jere Dhananjay, Chu Hyuk, Song Man Ki, Kim Dong Wook, Jang Yong-Suk, Yang Moon-Sik, Han Seung Hyun, Park Yong-Ho, Cho Chong-Su, Yun Cheol-Heui

Primary Institution: Seoul National University

Hypothesis

Can intranasal immunization with PEI/pci-S nanoparticles induce effective immune responses against SARS-CoV?

Conclusion

Intranasal immunization with PEI/pci-S nanoparticles induces antigen-specific humoral and cellular immune responses.

Supporting Evidence

  • Mice immunized with PEI/pci-S nanoparticles produced significantly higher S-specific IgG1 and mucosal IgA.
  • The number of B220+ cells was elevated in PEI/pci-S vaccinated mice.
  • Co-stimulatory molecules and MHC class II molecules were increased on dendritic cells after vaccination.

Takeaway

The study shows that a new way of giving a vaccine through the nose can help the body fight off a virus called SARS.

Methodology

BALB/c mice were immunized intranasally with PEI/pci-S complexes and immune responses were measured.

Limitations

The study was conducted in mice, and results may not directly translate to humans.

Participant Demographics

Female BALB/c mice, aged six to eight weeks.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2172-11-65

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication